3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
74
Burkitt Lymphoma
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
17
Leukemia, Biphenotypic, Acute
15
Myelodysplastic Syndromes
13
Leukemia
11
Myeloproliferative Disorders
7
Lymphoma, Mantle-Cell
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Recurrence
5
Sarcoma, Myeloid
4
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Leukemia, Myelomonocytic, Chronic
4
Blast Crisis
4
Leukemia, Monocytic, Acute
3
Hematologic Neoplasms
3
Down Syndrome
3
Lymphoma, T-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Myeloid
2
Hodgkin Disease
2
Anemia, Refractory, with Excess of Blasts
2
Thrombocythemia, Essential
1
Targeted Therapy
1
Interventions
peginterferon alfa-2b
1
liposomal doxorubicin
1
dolutegravir
1
belinostat
1
Zidovudine
1
Tenofovir
1
Taxes
1
Paclitaxel
1
Lomustine
1
Irinotecan
1
Introns
1
Gemcitabine
1
Doxorubicin
1
Cyclophosphamide
1
Carboplatin
1
Albumin-Bound Paclitaxel
1
3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia-Lymphoma, Adult T-Cell
×
Cytarabine
×
90 days
×
Clear all
No trials found.